Acepodia
1 known investors
Acepodia is a clinical-stage biotechnology company developing cell therapies for cancer using its Antibody-Cell Conjugation (ACC) platform, which attaches tumor-targeting antibodies to immune cells without genetic engineering. It focuses on immune cell engagers for hematologic and solid tumor cancers.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Acepodia do?
- Acepodia is a clinical-stage biotechnology company developing cell therapies for cancer using its Antibody-Cell Conjugation (ACC) platform, which attaches tumor-targeting antibodies to immune cells without genetic engineering. It focuses on immune cell engagers for hematologic and solid tumor cancers.
- Who are Acepodia's investors?
- Acepodia's investors include Maxpro Ventures.